The downgrade by a major financial institution like UBS, accompanied by a significant reduction in the price target, typically leads to a negative short-term impact on the stock price. Investors often react to such analyst ratings changes, especially when it involves a shift from a positive to a neutral stance and a substantial lowering of the price target, indicating a revised outlook on the company's future performance.